REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

Historical Holders from Q4 2020 to Q2 2025

Symbol
RVPH on Nasdaq
CUSIP
76152G100
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
14.3M
Holdings value
$5.44M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
44
Number of buys
19
Number of sells
-21
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 9.9% $4.08M 8M HIGHBRIDGE CAPITAL MANAGEMENT, LLC Jun 30, 2025
SAXENA PARAG 6.2% -27.8% $3.19M 6.26M 0% Parag Saxena Sep 22, 2025
683 Capital Management, LLC 5.36% $2.77M 5.44M 683 CAPITAL MANAGEMENT, LLC Sep 22, 2025
Bhat Laxminarayan 3.8% -28% $1.88M $34.9K 3.68M +1.9% Bhat Laxminarayan Sep 22, 2025
CVI Investments, Inc. 4.9% -16.7% $1.82M -$218K 3.57M -10.7% CVI Investments, Inc. Jun 30, 2025
TANG CAPITAL MANAGEMENT LLC 4.8% -37.5% $1.73M -$260K 3.4M -13.1% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
Schonfeld Strategic Advisors LLC 2.82% $763K 1.31M Schonfeld Strategic Advisors LLC Dec 31, 2024

Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 14.3M $5.44M +$2.03M $0.38 44
2025 Q1 7.32M $6.94M -$2.15M $0.95 47
2024 Q4 7.73M $14M -$4.02M $1.81 42
2024 Q3 9.95M $14.9M +$4.67M $1.44 33
2024 Q2 6.85M $8.75M +$1.34M $1.28 32
2024 Q1 5.57M $21M -$1.86M $3.78 30
2023 Q4 10.4K $53.4K $5.15 1
2023 Q3 2.66M $13M -$557K $4.88 24
2023 Q2 2.64M $15.4M +$8.42M $5.86 22
2023 Q1 1.38M $5.76M +$298K $4.19 22
2022 Q4 1.3M $5.54M +$2.02M $4.25 24
2022 Q3 866K $1.38M -$906K $1.59 15
2022 Q2 1.87M $2.05M -$115K $1.10 11
2022 Q1 1.9M $4.68M -$2.06M $2.46 14
2021 Q4 2.61M $7.54M -$15.6K $2.89 11
2021 Q3 2.6M $10.5M -$230K $4.06 11
2021 Q2 2.65M $12.8M +$9.61M $4.86 11
2021 Q1 586K $3.37M +$1.29M $5.74 7
2020 Q4 360K $3.15M +$3.15M $8.77 3